Neuromod Devices
PrivateLast Round
Series B
Extension
Mar 11, 2025
Total Funding Raised
$62.32M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Neuromod Devices is a medical device company that specializes in the design and development of neuromodulation technologies to address the clinical needs of people living with chronic and debilitating conditions.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT
Business Model
B2B2C
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neuromod Devices Comparables
Compare Neuromod Devices with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Auricle | 85% | |
| Otoharmonics Corporation | 79% | |
| Duearity | 73% |
Neuromod Devices Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Mar 11, 2025 | ||||
| Series B | Apr 13, 2023 | ||||
| Debt | Apr 13, 2023 | ||||
| Series B | Oct 20, 2020 | ||||
| VC Round | Sep 26, 2019 | ||||
Series A | Sep 29, 2015 |
Key People
Founding team and executive leadership
Neuromod Devices Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kreos Capital | Series B, VC Round |
| Fountain Healthcare Partners | Series B, VC Round, Series A, Series B Extension |
| European Investment Bank Group | Debt, Series B |
| Panakès Partners | Series B, Series B Extension |
| Silicon Valley Bank | Series B, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 90% MoM.
- Mar 11, 2025
$11M round led by Fountain Healthcare Partners and Panakès Partners.
Recent news
Latest coverage and updates
- launchesSep 9, 2026
Neuromod Devices Limited is launching Lenire, a bimodal neuromodulation device that provides long-term tinnitus relief, in Australia, where it is now available following inclusion in the Australian Register of Therapeutic Goods, in Sep '26.
Neuromod Devices Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Neuromod Devices's valuation, stock price, and market status.
Is Neuromod Devices a public or private company?
Neuromod Devices is a private company.
What is the current stock price of Neuromod Devices?
Neuromod Devices is a private company, so its shares have no public market price. Caplight tracks Neuromod Devices's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Neuromod Devices worth (valuation)?
Valuation information for Neuromod Devices is not publicly available.
Can I buy Neuromod Devices stock?
Neuromod Devices shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Neuromod Devices's last funding round?
Neuromod Devices's most recent funding round was Series B Extension on March 11, 2025.
Who are the main investors in Neuromod Devices?
Key investors in Neuromod Devices include Fountain Healthcare Partners, Panakès Partners.
Will Neuromod Devices IPO soon?
No public IPO plans have been announced for Neuromod Devices.
How can I track Neuromod Devices secondary market activity?
Caplight tracks bids, offers, and trades in Neuromod Devices's shares on secondary markets.